HOME >> BIOLOGY >> NEWS
UIC scientists provide first images of HIV in living cells

In stunning color images using time-lapse microscopy, researchers at the University of Illinois at Chicago have for the first time captured the very earliest stages of HIV infection in living cells.

The researchers filmed individual HIV particles as they traveled to the nucleus of a human cell and began taking over its genetic machinery -- the first step in the destruction of the body's immune system that leads to AIDS.

The movies not only offer tantalizing glimpses of HIV in action, but provide visual proof that HIV enlists the assistance of its host to wreak havoc on the body's defenses.

The virus can be seen traveling along a part of the host cell's own skeletal framework of microtubules as it makes its way from the outer membrane to the nucleus. The virus hitches a ride aboard a multi-unit protein called dynein, commonly referred to as a molecular motor.

"Dynein is like a tractor trailer, the microtubules are the highway, and the HIV particles are the cargo," said David McDonald, assistant professor of microbiology and immunology at UIC.

McDonald and Thomas Hope, associate professor of microbiology and immunology at UIC, are co-authors of the study, which appeared Nov. 11 in the Journal of Cell Biology. Science magazine named the paper an "editor's choice" in its Nov. 22 issue, and it will be featured in an upcoming issue of Nature Cell Biology.

An editorial accompanying the paper said, "With the powerful approaches developed by McDonald et al. and the incredible progress in imaging single fluorescent molecules in living cells, ... important and fascinating questions of HIV cell biology can now be addressed."

Until recently, little was known about how HIV enters a cell. The virus is made of an outer shell, or envelope, and a core, referred to as a particle, which is composed of proteins and genetic material. When the virus attacks an immune cell, it fuses with the cell's membrane and releases its particl
'"/>

Contact: Sharon Butler
sbutler@uic.edu
312-355-2522
University of Illinois at Chicago
11-Dec-2002


Page: 1 2 3

Related biology news :

1. DNA lends scientists a hand, revealing new chemical reactions
2. Conference at UH opens doors for new scientists, engineers
3. Wisconsin scientists develop quick botox test
4. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
5. Alaska scientists find Arctic tundra yields surprising carbon loss
6. UAF scientists discover new marine habitat in Alaska
7. Information system to help scientists analyze mechanisms of social behavior
8. Zoonotic diseases - European scientists unite to fight diseases
9. Israeli scientists reveal the plan of a key cellular machine
10. Study by Israeli scientists provides insight on DNA code
11. Computer scientists at UH developing nurturing computers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UIC scientists provide first images HIV living cells

(Date:5/24/2013)... for medication against Alzheimer,s disease, scientists have focused among ... beta (A-beta). After all, it is the accumulation of A-beta ... patients. Starting point for the formation of A-beta is APP. ... to unravel the function of APPL the fruit-fly version ... , Alessia Soldano (VIB/KU Leuven): "We have discovered that ...
(Date:5/23/2013)... to be the world,s most popular fruit, can be ... with purple GM varieties. , "Working with GM ... the addition of a specific compound, allows us to ... Professor Cathie Martin from the John Innes Centre. , ... better flavour, health and shelf life characteristics because even ...
(Date:5/23/2013)... School of Public Health at Emory University, along ... have received a $4 million grant over four ... University (Health and Exposome Research Center: Understanding Lifetime ... grant awarded in the United States. , ... Institute of Environmental Health Sciences (NIEHS) of the ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2The world's favorite fruit only better-tasting and longer-lasting 2Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... May 23, 2013 BioTrends Research Group, ... firms for specialized biopharmaceutical issues, finds that, unaided, ... disease specialists reported that in the past six ... delaying treatment) in anticipation of the next generation ... ago, when only 6 percent reported that they ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
Cached News: